Influence of Dietary Sodium on Renal Function in Patients with Chronic Renal Disease

1965 ◽  
Vol 62 (2) ◽  
pp. 231 ◽  
Author(s):  
DANIEL M. LEVIN
Keyword(s):  
Renal Function ◽  
Renal Disease ◽  
Chronic Renal Disease ◽  
Dietary Sodium

Chronic renal disease in pregnancy: obstetric outcomes and effect of pregnancy on renal function

2011 ◽  
Vol 96 (Supplement 1) ◽  
pp. Fa102-Fa102
Author(s):  
T. J. Bonnett ◽  
A. Khalid ◽  
D. Throssell ◽  
T. Farrell ◽  
R. P. Jokhi
Keyword(s):  
Renal Function ◽  
Renal Disease ◽  
Chronic Renal Disease ◽  
Obstetric Outcomes ◽  
In Pregnancy

The Use of Frusemide and Propranolol in the Treatment of the Hypertension of Chronic Renal Disease

1974 ◽  
Vol 19 (1_suppl) ◽  
pp. 25-32 ◽  
Author(s):  
R. Wilkinson ◽  
Mary Pickering ◽  
Valerie Robson ◽  
R. W. Elliott ◽  
D. N. S. Kerr
Keyword(s):  
Blood Pressure ◽  
Renal Function ◽  
Renal Disease ◽  
Serum Creatinine ◽  
Marked Reduction ◽  
Chronic Renal Disease ◽  
Plasma Renin ◽  
Sodium Retention ◽  
Exchangeable Sodium ◽  
Standing Blood Pressure

Nine patients with renal disease, hypertension and impairment of renal function of varying degree have been studied before and during treatment with frusemide. In three patients observations were repeated following the addition of propranolol. In most cases frusemide resulted in a reduction of both lying and standing blood pressure but for the group the fall was not significant (P>0.05). In all patients a reduction in exchangeable sodium was achieved and the fall was significant for the group (P<0.05); this was accompanied by a significant increase in serum creatinine (P < 0.05). Plasma renin activity was increased in all patients during treatment with frusemide and the change for the group was significant (P<0.05). The addition of propranolol resulted in a marked reduction in renin in the three patients treated but in two blood pressure actually rose; in these two sodium retention had occurred following the introduction of propranolol.

scholarly journals Measurement of renal function in chronic renal disease

1990 ◽  
Vol 38 (1) ◽  
pp. 167-184 ◽  
Author(s):  
Principal discussant: Andrew S. Levey
Keyword(s):  
Renal Function ◽  
Renal Disease ◽  
Chronic Renal Disease

Effects of protein intake variation and omega-3 polyunsaturated fatty acids on renal function in chronic renal disease

Life Sciences ◽  
1987 ◽  
Vol 41 (25) ◽  
pp. 2759-2765 ◽  
Author(s):  
G.H. Schaap ◽  
H.J.G. Bilo ◽  
C. Popp-Snijders ◽  
P.L. Oe ◽  
C. Mulder ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Renal Function ◽  
Renal Disease ◽  
Polyunsaturated Fatty Acids ◽  
Protein Intake ◽  
Chronic Renal Disease ◽  
Omega 3

scholarly journals Effect of Gender on the Progression of Nondiabetic Renal Disease

2000 ◽  
Vol 11 (2) ◽  
pp. 319-329
Author(s):  
JOEL NEUGARTEN ◽  
ANJALI ACHARYA ◽  
SHARON R. SILBIGER
Keyword(s):  
Renal Function ◽  
Renal Disease ◽  
Chronic Renal Disease ◽  
Meta Analysis ◽  
Male Gender ◽  
Rapid Decline ◽  
Rapid Rate ◽  
Published Evidence ◽  
Rate Of Progression

There is previously published evidence that male gender is associated with a more rapid rate of progression of nondiabetic chronic renal disease. However, some investigators have concluded that no such association exists. To help resolve this issue, a meta-analysis was performed using 68 studies that met defined criteria and contained a total of 11,345 patients to evaluate the effect of gender on the progression of nondiabetic chronic renal disease. The results indicate that men with chronic renal disease of various etiologies show a more rapid decline in renal function with time than do women.

scholarly journals Hypoglycemic therapy in patients on hemodialysis and peritoneal dialysis

2010 ◽  
Vol 13 (4) ◽  
pp. 87-92
Author(s):  
Irina Arkad'evna Bondar' ◽  
Vadim Valer'evich Klimontov
Keyword(s):  
Diabetes Mellitus ◽  
Renal Function ◽  
Diabetic Nephropathy ◽  
Peritoneal Dialysis ◽  
Renal Insufficiency ◽  
Renal Disease ◽  
Carbohydrate Metabolism ◽  
Chronic Renal Disease ◽  
Developed Countries ◽  
Hypoglycemic Therapy

Diabetes mellitus (DM) is a leading cause of renal insufficiency in developed countries. Most cases of chronic renal disease in DM patients are dueto diabetic nephropathy. The impairment of renal function at later stages of diabetic nephropathy is accompanied by complicated changes in the regulationof carbohydrate metabolism most of which require hypoglycemic therapy to be corrected

Severe Tetany in an Azotemic Child Related to a Sodium Phosphate Enema

PEDIATRICS ◽  
1974 ◽  
Vol 53 (1) ◽  
pp. 105-106
Author(s):  
Sarah C. Oxnard ◽  
John O'Bell ◽  
Warren E. Grupe
Keyword(s):  
Renal Function ◽  
Renal Disease ◽  
Chronic Constipation ◽  
Sodium Phosphate ◽  
Chronic Renal Disease ◽  
Potential Toxicity ◽  
Phosphate Enema ◽  
Hirschprung's Disease ◽  
Neutral Sodium ◽  
Carpopedal Spasm

The potential toxicity of neutral sodium phosphate medications to infants and azotemic children is rarely taken into consideration. Since the sole route of excretion of absorbed phosphate is renal, diminished renal function secondary to chronic renal disease or renal immaturity will limit the ability to excrete a sudden phosphate load. Previous reports document toxicity of phosphate laxatives to normal infants and hypertonic phosphate enemas to patients with Hirschprung's disease. This report presents a 4½-year-old azotemic boy who was admitted with carpopedal spasm and acidosis in the presence of profound hyperphosphatemia, following administration of a sodium phosphate enema for chronic constipation.

RENAL FUNCTION IN CHRONIC RENAL DISEASE

Medicine ◽  
1965 ◽  
Vol 44 (4) ◽  
pp. 263-288 ◽  
Author(s):  
NEAL S. BRICKER ◽  
SAULO KLAHR ◽  
HERBERT LUBOWITZ ◽  
RICHARD E. RIESELBACH
Keyword(s):  
Renal Function ◽  
Renal Disease ◽  
Chronic Renal Disease
Sign in / Sign up

Export Citation Format

Share Document